Empagliflozin 5mg + Metformin 500mg: Uses, Benefits & Precautions
EMPATECH MET 5/500 contains Empagliflozin 5mg and Metformin Hydrochloride 500mg and is marketed by Steris Healthcare. This combination is used as part of a comprehensive treatment plan for type 2 diabetes mellitus, along with appropriate diet, physical activity and regular medical monitoring.
Empagliflozin belongs to the sodium-glucose cotransporter-2 (SGLT2) inhibitor class, while metformin is a biguanide antidiabetic medicine. Their complementary mechanisms help lower elevated blood glucose through different pathways.
What is EMPATECH MET 5/500 Used For?
Empagliflozin 5mg, Metformin Hydrochloride 500mg is used to help improve blood glucose control in adults with type 2 diabetes mellitus when treatment with one medicine alone may not provide adequate glycemic control or when combination therapy is considered appropriate.
Empagliflozin helps the kidneys remove excess glucose through urine, whereas metformin primarily decreases glucose production by the liver and improves insulin sensitivity. Together, these medicines can provide complementary blood-glucose-lowering effects.
EMPATECH MET 5/500 is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis unless specifically directed in a specialized medical setting.
Why is Empagliflozin and Metformin Important?
Type 2 diabetes is characterized by elevated blood glucose associated with insulin resistance, inadequate insulin activity and increased glucose production. Persistent hyperglycemia can increase the risk of complications affecting the cardiovascular system, kidneys, eyes and nerves.
Using medicines with different mechanisms can help target more than one aspect of abnormal glucose metabolism.
Metformin reduces hepatic glucose production and improves the body's response to insulin. Empagliflozin promotes urinary glucose excretion by inhibiting SGLT2 in the kidneys.
Along with lifestyle measures, appropriate glucose-lowering therapy can help patients work toward individualized blood-glucose targets and reduce the long-term impact of uncontrolled diabetes.
Key Benefits
What are the Benefits?
When prescribed appropriately, EMPATECH MET 5/500 may provide the following benefits:
Helps lower elevated blood glucose in adults with type 2 diabetes.
Combines two glucose-lowering medicines with complementary mechanisms.
Metformin helps reduce excessive glucose production by the liver.
Empagliflozin increases urinary glucose excretion.
May improve overall glycemic control when combination therapy is appropriate.
Empagliflozin may provide additional cardiovascular and kidney-related benefits in certain eligible patients, depending on their clinical condition and indication.
Can be used alongside diet, physical activity and regular diabetes monitoring.
The expected benefits vary according to individual health status, kidney function, diabetes control and treatment plan.
Side Effects
Like other prescription medicines, Empagliflozin 5mg and Metformin Hydrochloride 500mg may cause side effects.
Common or possible effects include:
Increased urination
Increased thirst
Nausea
Diarrhea
Abdominal discomfort
Reduced appetite
Genital fungal infections
Urinary tract infections
Dehydration or dizziness, particularly in susceptible individuals
Gastrointestinal effects are commonly associated with metformin, especially when treatment is initiated or the dose is increased. Increased urination and genital infections may occur with empagliflozin because of increased glucose excretion in the urine.
Serious Side Effects
Seek urgent medical attention if symptoms suggest a serious adverse reaction, including:
Severe dehydration or fainting
Severe genital or perineal pain with swelling, redness or fever
Symptoms suggestive of diabetic ketoacidosis, such as nausea, vomiting, abdominal pain, unusual tiredness or difficulty breathing
Severe allergic reaction
Persistent or severe weakness
Severe metabolic symptoms associated with lactic acidosis, such as unusual weakness, breathing difficulty, persistent vomiting or severe abdominal discomfort
The risk of metformin-associated lactic acidosis is higher in certain people, particularly those with significant kidney impairment or other conditions that predispose to poor oxygenation or impaired lactate clearance.
Available Substitute
There is no single universal substitute for EMPATECH MET 5/500. Alternatives depend on the patient's blood glucose levels, kidney function, cardiovascular and renal status, other medicines, tolerance and treatment goals.
Possible treatment approaches may include:
Metformin alone
An empagliflozin-containing combination with a different strength
Other SGLT2 inhibitor combinations
Metformin combined with another class of glucose-lowering medicine
Other individualized diabetes treatment regimens
A doctor should determine whether a substitute is appropriate. Patients should not switch, stop or change diabetes medication without professional guidance.
Dosage Guidelines
Take EMPATECH MET 5/500 exactly as prescribed by the healthcare professional.
General precautions for use include:
Take the medicine according to the prescribed schedule.
Follow the instructions regarding whether it should be taken with food.
Swallow the tablet as directed.
Maintain adequate fluid intake unless fluid restriction has been advised.
Monitor blood glucose as recommended.
Do not take an additional dose to compensate for a missed dose without appropriate guidance.
Do not discontinue diabetes treatment abruptly without consulting the prescriber.
The appropriate dose depends on previous diabetes therapy, glycemic control, kidney function and tolerability. Dose selection should therefore be individualized.
Precautions & Warnings
Before using Empagliflozin 5mg, Metformin Hydrochloride 500mg, tell your healthcare professional if you have:
Kidney disease or reduced kidney function
Liver disease
A history of diabetic ketoacidosis
Recurrent urinary or genital infections
Low blood pressure or dehydration
Heart failure or cardiovascular disease
A history of pancreatitis
A planned surgery
A planned imaging procedure involving iodinated contrast
A condition associated with prolonged fasting or reduced food intake
Mechanism of Action
EMPATECH MET 5/500 works through two complementary mechanisms.
How Empagliflozin Works
Empagliflozin selectively inhibits sodium-glucose cotransporter-2 (SGLT2) in the proximal renal tubules. SGLT2 normally reabsorbs a significant portion of filtered glucose back into the bloodstream.
By inhibiting this transporter, empagliflozin reduces renal glucose reabsorption and increases glucose elimination through urine. This lowers blood glucose independently of insulin.
The increased urinary glucose excretion also produces an osmotic diuretic effect, which can contribute to increased urination and fluid loss.
How Metformin Works
Metformin primarily reduces hepatic glucose production, particularly gluconeogenesis. It also improves insulin sensitivity and increases peripheral glucose utilization.
Unlike some insulin-secretagogue medicines, metformin generally does not stimulate pancreatic insulin release directly and therefore has a relatively low risk of causing hypoglycemia when used alone.
Combined Effect
The two medicines reduce blood glucose through different pathways:
Empagliflozin → increases urinary glucose excretion
Metformin → reduces hepatic glucose production and improves insulin sensitivity
This complementary action makes the combination useful for selected adults with type 2 diabetes when combination treatment is medically appropriate.
Conclusion
EMPATECH MET 5/500, containing Empagliflozin 5mg and Metformin Hydrochloride 500mg, is a prescription combination marketed by Steris Healthcare for the management of type 2 diabetes mellitus in appropriate patients.
Metformin primarily decreases glucose production by the liver and improves insulin sensitivity, while empagliflozin lowers blood glucose by increasing urinary glucose excretion through SGLT2 inhibition. Their complementary actions can support improved glycemic control when combination therapy is clinically appropriate.
Patients should use EMPATECH MET 5/500 only according to their healthcare professional's instructions, with appropriate attention to kidney function, hydration and potential adverse effects. Symptoms such as severe dehydration, unusual breathing difficulty, persistent vomiting, abdominal pain or signs of a serious infection require prompt medical evaluation.
EMPATECH MET 5/500 should be used as part of an individualized diabetes-management plan that includes appropriate diet, physical activity, blood-glucose monitoring and regular medical follow-up.
Comments
Post a Comment